Literature DB >> 24216107

Quercetin-3-O-glucuronide induces ABCA1 expression by LXRα activation in murine macrophages.

Kazuaki Ohara1, Hideyuki Wakabayashi, Yoshimasa Taniguchi, Kazutoshi Shindo, Hiroaki Yajima, Aruto Yoshida.   

Abstract

Reverse cholesterol transport (RCT) removes excess cholesterol from macrophages to prevent atherosclerosis. ATP-binding cassette, subfamily A, member 1 (ABCA1) is a crucial cholesterol transporter involved in RCT to produce high density lipoprotein-cholesterol (HDLC), and is transcriptionally regulated by liver X receptor alpha (LXRα), a nuclear receptor. Quercetin is a widely distributed flavonoid in edible plants which prevented atherosclerosis in an animal model. We found that quercetin-3-O-glucuronide (Q3GA), a major quercetin metabolite after absorption from the digestive tract, enhanced ABCA1 expression, in vitro, via LXRα in macrophages. In addition, leaf extracts of a traditional Asian edible plant, Nelumbo nucifera (NNE), which contained abundant amounts of quercetin glycosides, significantly elevated plasma HDLC in mice. We are the first to present experimental evidence that Q3GA induced ABCA1 in macrophages, and to provide an alternative explanation to previous studies on arteriosclerosis prevention by quercetin.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ABCA1; ATP-binding cassette, subfamily A, member 1; HDL; HDLC; LXRα; Macrophage; NNE; Nelumbo nucifera; Nelumbo nucifera leaf extracts; Q3GA; Quercetin-3-O-glucuronide; RCT; high density lipoprotein; high density lipoprotein-cholesterol; liver X receptor alpha; quercetin-3-O-glucuronide; reverse cholesterol transport

Mesh:

Substances:

Year:  2013        PMID: 24216107     DOI: 10.1016/j.bbrc.2013.10.168

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  Pioglitazone reduces lipid droplets in cholesterolosis of the gallbladder by increasing ABCA1 and NCEH1 expression.

Authors:  Jing-Min Wang; Dong Wang; Yu-Yan Tan; Gang Zhao; Zhen-Ling Ji
Journal:  Mol Cell Biochem       Date:  2014-10-04       Impact factor: 3.396

2.  Pharmacokinetic comparison between quercetin and quercetin 3-O-β-glucuronide in rats by UHPLC-MS/MS.

Authors:  Le-Le Yang; Na Xiao; Xiao-Wei Li; Yong Fan; Raphael N Alolga; Xiao-Yue Sun; Shi-Lei Wang; Ping Li; Lian-Wen Qi
Journal:  Sci Rep       Date:  2016-10-24       Impact factor: 4.379

Review 3.  The Use of Nutraceuticals to Counteract Atherosclerosis: The Role of the Notch Pathway.

Authors:  Giorgio Aquila; Luisa Marracino; Valeria Martino; Donato Calabria; Gianluca Campo; Cristiana Caliceti; Paola Rizzo
Journal:  Oxid Med Cell Longev       Date:  2019-05-02       Impact factor: 6.543

4.  Tacrolimus reduces atherosclerotic plaque formation in ApoE-/- mice by inhibiting NLRP3 inflammatory corpuscles.

Authors:  Xiao Li; Xingfu Shang; Lu Sun
Journal:  Exp Ther Med       Date:  2019-12-17       Impact factor: 2.447

5.  Fermentation of Vaccinium floribundum Berries with Lactiplantibacillus plantarum Reduces Oxidative Stress in Endothelial Cells and Modulates Macrophages Function.

Authors:  Luisa Marracino; Angela Punzo; Paolo Severi; Rosane Nganwouo Tchoutang; Celia Vargas-De-la-Cruz; Francesca Fortini; Francesco Vieceli Dalla Sega; Alessia Silla; Emanuele Porru; Patrizia Simoni; Valentina Rosta; Alessandro Trentini; Achille Wilfred Ouambo Talla; Silvana Hrelia; Carlo Cervellati; Paola Rizzo; Cristiana Caliceti
Journal:  Nutrients       Date:  2022-04-08       Impact factor: 6.706

6.  The molecular mechanism of the cholesterol-lowering effect of dill and kale: The influence of the food matrix components.

Authors:  Francesca Danesi; Marco Govoni; Luigi Filippo D'Antuono; Alessandra Bordoni
Journal:  Electrophoresis       Date:  2016-04-24       Impact factor: 3.535

Review 7.  Natural Products Targeting Liver X Receptors or Farnesoid X Receptor.

Authors:  Jianglian She; Tanwei Gu; Xiaoyan Pang; Yonghong Liu; Lan Tang; Xuefeng Zhou
Journal:  Front Pharmacol       Date:  2022-01-05       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.